What should I do if a family member or coworker is diagnosed with TB? 

When a close contact is diagnosed with tuberculosis (TB), it is natural to feel concerned about your own health and the safety of those around you. Tuberculosis is a bacterial infection spread through the air, but it typically requires prolonged and close contact for transmission to occur. In the United Kingdom, the management of tuberculosis exposure is highly structured and led by specialist public health teams. The focus of these teams is to identify individuals at risk, provide necessary screening, and offer preventative treatment where appropriate. By following established clinical protocols, the spread of the infection can be contained, and those exposed can receive the care needed to maintain their health. 

What We’ll Discuss in This Article 

• The role of the specialist TB nursing team in contact tracing. 

• How the NHS defines a close contact in household and workplace settings. 

• The clinical testing process for individuals exposed to active TB. 

• Why most workplace exposures are considered low risk. 

• Practical steps to support a colleague or relative during their recovery. 

• The difference between latent and active infection following exposure. 

The role of the specialist TB contact tracing team 

If a family member or coworker is diagnosed with active tuberculosis, the local NHS TB service will initiate a formal contact tracing investigation to protect those who may have been exposed. Tuberculosis is a reportable disease in the UK, and specialist TB nurses are responsible for identifying and screening close contacts of people with active pulmonary or laryngeal TB. This team will interview the person diagnosed to understand who they spend the most time with and in what environments. If you are identified as a close contact, the team will reach out to you directly to explain the situation and invite you for a health assessment. You do not need to take immediate action yourself unless you are experiencing symptoms, as the public health team manages the prioritisation of screening based on the level of risk. 

Defining close contact in different environments 

Not everyone who has been in the vicinity of a person with tuberculosis will require screening, as the risk of catching the bacteria depends on the proximity and duration of the exposure. Household members who share a living space with someone who has active TB are at the highest risk and are always prioritised for screening. In a workplace setting, the criteria are more specific, usually focusing on coworkers who share an office or workstation for a significant amount of time, typically defined as more than eight hours cumulatively. Casual contact, such as sharing a lift, passing in a corridor, or attending a brief meeting, is generally considered a negligible risk and does not usually warrant clinical testing. 

The clinical screening process for contacts 

If you are called for screening, the process is designed to detect both active disease and latent (dormant) infection. Screening for close contacts of a person with active TB usually involves a symptom check, a clinical examination, and an immune system test such as the Mantoux skin test or an IGRA blood test. The choice of test depends on your age, your vaccination history, and your general health. If these tests indicate that you have been infected, you will usually be referred for a chest X-ray to see if the disease is active in your lungs. If the X-ray is clear and you have no symptoms, you may be offered a course of preventative antibiotics to ensure the infection does not become active in the future. 

Managing the first two weeks of exposure 

For family members living with a person newly diagnosed with active pulmonary TB, the first two weeks of the patient’s treatment are the most critical for infection control. Most people with active pulmonary TB are no longer infectious after they have been on the correct antibiotic treatment for two weeks. During this time, it is advisable to keep the home well-ventilated by opening windows and to encourage the patient to cover their mouth with a tissue when coughing. In a workplace, a colleague with active TB is typically advised to stay at home during these first two weeks. Once they are confirmed to be non-infectious by their medical team, they can safely return to work without posing a risk to others. 

Supporting a colleague or relative during recovery 

Supporting someone through tuberculosis treatment involves encouraging them to adhere to their long-term medication schedule. Tuberculosis treatment lasts for at least six months, and missing doses can increase the risk of the bacteria returning or becoming drug-resistant. You can help by providing emotional support and reducing the stigma associated with the diagnosis. It is important to remember that tuberculosis is not spread through touch or by sharing household items like cups and cutlery. Normal household activities can continue as usual, and once the infectious period has passed, there are no restrictions on socialising or working alongside the individual. 

Conclusion 

Being a contact of someone with tuberculosis requires a calm and structured response following the guidance of the local NHS TB team. While household members are at a higher risk and require priority screening, most workplace exposures are low risk and are managed through targeted testing. By participating in the screening process and supporting the patient through their six-month treatment course, you can protect your own health and contribute to the safety of your community. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article is designed to provide clear, clinically safe guidance for individuals who may have been exposed to tuberculosis in the United Kingdom. All information is strictly aligned with the evidence-based protocols established by the NHS and the National Institute for Health and Care Excellence (NICE). This content was authored by a medical content team and reviewed by Dr. Stefan Petrov, a UK-trained physician, to ensure clinical accuracy and safety.